Results 161 to 170 of about 77,701 (209)

High-Dimensional Propensity Scores for Mitigating Confounding: Implementation Using Primary and Secondary Care Data in Hong Kong. [PDF]

Pharmacoepidemiol Drug Saf
Cheung ECL, Fan M, Chui CSL, Wong AYS, Tazare J.   +4 more
europepmc   +1 more source

A promise to save 100,000 trauma patients.

, 2013
Horton, Richard, Krug, Etienne, Mersch, Jeannot, Piot, Peter, Roberts, Ian, Shakur, Haleema   +5 more
core   +1 more source

Effects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells. [PDF]

Int J Mol Sci
Delforce SJ, Mohammed R, Symington TL, Wang Y, Verrills NM, Lumbers ER, Pringle KG.   +6 more
europepmc   +1 more source

Diabetic Kidney Disease: From Pathophysiology to Treatment Perspectives.

Kidney Blood Press Res
Varda L, Vreča N, Ekart R, Bevc S, Piko N.   +4 more
europepmc   +1 more source

Long-Term Safety and Effectiveness of Calcium Channel Blockers in Hypertension: A Systematic Review. [PDF]

Drug Healthc Patient Saf
Aisyah N, Aurellia JS, Insani WN.
europepmc   +1 more source

Timing insights in losartan-induced pancreatitis: a clinical case report. [PDF]

Oxf Med Case Reports
Karanjit S, Shahi N, Shahi KR, Chapagain D, Jha JB, Gyawali J.   +5 more
europepmc   +1 more source

Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice? [PDF]

Int J Mol Sci
Seidita A, Buscemi C, Di Liberto D, Pistone M, Maestri S, Cavallo G, Cosenza S, Spagnuolo G, Giuliano A, Carlisi D, Pratelli G, Mandreucci F, Carroccio A.   +12 more
europepmc   +1 more source

Long-term mortality and treatment outcomes in pacemaker-associated heart failure: insights from a nationwide propensity-matched study. [PDF]

Eur Heart J Open
Park YJ, Lee S, Hong S, Kim K, Kim J, Kim JY, Park KM, On YK, Park SJ.   +8 more
europepmc   +1 more source

Angiotensin-(1-7) Alleviates Isoproterenol-Induced Cardiac Hypertrophy by Suppressing Autophagy and Apoptosis Through the Synergistic Action of Mas Receptor and Angiotensin II Type 2 Receptor. [PDF]

Acta Physiol (Oxf)
Wang X, Guo F, Wang X, Guo Y, Fan S, Hong L, Jin H.   +6 more
europepmc   +1 more source

Effects of sacubitril/valsartan on ventricular remodeling in patients with hypertension and maintenance hemodialysis: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Jiang L, Min X, Ran J, Zhu Y, Pan L, Yang B, Ran X, Ran Y, Ding H, Yang J, Wu S.   +10 more
europepmc   +1 more source